Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club
Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical...
Gespeichert in:
| Veröffentlicht in: | Osteoporosis international 2010-10, Vol.21 (10), p.1657-1680 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1680 |
|---|---|
| container_issue | 10 |
| container_start_page | 1657 |
| container_title | Osteoporosis international |
| container_volume | 21 |
| creator | Body, J.-J Bergmann, P Boonen, S Boutsen, Y Devogelaer, J.-P Goemaere, S Kaufman, J.-M Rozenberg, S Reginster, J.-Y |
| description | Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the specificities of each and every health care environment. The present manuscript is the result of a National Consensus, based on a systematic review and a critical appraisal of the currently available literature. It offers an evidence-based update of previous treatment guidelines, with the aim of providing clinicians with an unbiased assessment of osteoporosis treatment effect. |
| doi_str_mv | 10.1007/s00198-010-1223-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2931762</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2135492511</sourcerecordid><originalsourceid>FETCH-LOGICAL-c663t-d2942a0a926fc54af6da385a4c5c06df11013042728d2cfb26a95eacf25f8e813</originalsourceid><addsrcrecordid>eNqFUsuO1DAQjBCIHQY-gAtYSIhTwHZsJ-aAxI6Wh7QSB1iJm9Vx7IxXGTtrJyPtJ_DXeB7sAAc4uVtdVd3urqJ4SvBrgnH9JmFMZFNigktCaVWye8WCsKoqqRT8frHAsqpLycj3s-JRStc4c6SsHxZnFLMGE9Ysih8XW9cZr03ZQjId6uecDs6bhGyIaFobNK4hbkCHIfROw4CmaGDaGD-hYNEY0i4OI8wp13JmwhhiSC69RYB08Mn4NCfUBT3vSe3tXvXcDL0Dj86DN2g1zO3j4oGFIZknx3dZXH24-Lb6VF5--fh59f6y1EJUU9lRyShgkFRYzRlY0UHVcGCaayw6SwgmFWa0pk1HtW2pAMkNaEu5bUxDqmXx7qA7zu3GdDrPFGFQY3QbiLcqgFN_Vrxbqz5sFZUVqQXNAvQgMDjTGxVi69SW7on7eB56BVq1RlEqGlVjQngmvTp2jeFmNmlSG5e0GQbwJsxJSc4ExUKK_yJrzvIheb7zsnjxF_I6zNHn5WUQpqSmTGYQOYB0PkqKxt79lGC1c5E6uEjhXZ5dpHbCz35f0R3jl20y4OURAClbwkbw2qUTrqKs5nV9WlXKJd-beJrwX92fH0gWgoI-ZuGrr3R3VdI0nFFS_QQI2OsY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>750217249</pqid></control><display><type>article</type><title>Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Body, J.-J ; Bergmann, P ; Boonen, S ; Boutsen, Y ; Devogelaer, J.-P ; Goemaere, S ; Kaufman, J.-M ; Rozenberg, S ; Reginster, J.-Y</creator><creatorcontrib>Body, J.-J ; Bergmann, P ; Boonen, S ; Boutsen, Y ; Devogelaer, J.-P ; Goemaere, S ; Kaufman, J.-M ; Rozenberg, S ; Reginster, J.-Y</creatorcontrib><description>Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the specificities of each and every health care environment. The present manuscript is the result of a National Consensus, based on a systematic review and a critical appraisal of the currently available literature. It offers an evidence-based update of previous treatment guidelines, with the aim of providing clinicians with an unbiased assessment of osteoporosis treatment effect.</description><identifier>ISSN: 0937-941X</identifier><identifier>ISSN: 1433-2965</identifier><identifier>EISSN: 1433-2965</identifier><identifier>DOI: 10.1007/s00198-010-1223-4</identifier><identifier>PMID: 20480148</identifier><language>eng</language><publisher>London: London : Springer-Verlag</publisher><subject>Aged ; Aged, 80 and over ; Biological and medical sciences ; Bisphosphonate ; Bone Density Conservation Agents - therapeutic use ; Bones, joints and connective tissue. Antiinflammatory agents ; Consensus Statement ; Diphosphonates - therapeutic use ; Diseases of the osteoarticular system ; Drug therapy ; Endocrinology ; Estrogen Receptor Modulators - therapeutic use ; Estrogen Replacement Therapy ; Evidence-based medicine ; Evidence-Based Medicine - methods ; Female ; General & internal medicine ; Human health sciences ; Humans ; Medical sciences ; Medicine ; Medicine & Public Health ; Menopause ; Médecine générale & interne ; Organometallic Compounds - therapeutic use ; Orthopedics ; Osteoporosis ; Osteoporosis, Postmenopausal - drug therapy ; Osteoporosis. Osteomalacia. Paget disease ; Osteoporotic Fractures - prevention & control ; Pharmacology. Drug treatments ; Raloxifene ; Rheumatology ; Sciences de la santé humaine ; strontium ; Teriparatide ; Thiophenes - therapeutic use ; Womens health</subject><ispartof>Osteoporosis international, 2010-10, Vol.21 (10), p.1657-1680</ispartof><rights>The Author(s) 2010</rights><rights>2015 INIST-CNRS</rights><rights>International Osteoporosis Foundation and National Osteoporosis Foundation 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c663t-d2942a0a926fc54af6da385a4c5c06df11013042728d2cfb26a95eacf25f8e813</citedby><cites>FETCH-LOGICAL-c663t-d2942a0a926fc54af6da385a4c5c06df11013042728d2cfb26a95eacf25f8e813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00198-010-1223-4$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00198-010-1223-4$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,310,311,315,782,786,791,792,887,23937,23938,25147,27931,27932,41495,42564,51326</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23247577$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20480148$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Body, J.-J</creatorcontrib><creatorcontrib>Bergmann, P</creatorcontrib><creatorcontrib>Boonen, S</creatorcontrib><creatorcontrib>Boutsen, Y</creatorcontrib><creatorcontrib>Devogelaer, J.-P</creatorcontrib><creatorcontrib>Goemaere, S</creatorcontrib><creatorcontrib>Kaufman, J.-M</creatorcontrib><creatorcontrib>Rozenberg, S</creatorcontrib><creatorcontrib>Reginster, J.-Y</creatorcontrib><title>Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club</title><title>Osteoporosis international</title><addtitle>Osteoporos Int</addtitle><addtitle>Osteoporos Int</addtitle><description>Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the specificities of each and every health care environment. The present manuscript is the result of a National Consensus, based on a systematic review and a critical appraisal of the currently available literature. It offers an evidence-based update of previous treatment guidelines, with the aim of providing clinicians with an unbiased assessment of osteoporosis treatment effect.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Bisphosphonate</subject><subject>Bone Density Conservation Agents - therapeutic use</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Consensus Statement</subject><subject>Diphosphonates - therapeutic use</subject><subject>Diseases of the osteoarticular system</subject><subject>Drug therapy</subject><subject>Endocrinology</subject><subject>Estrogen Receptor Modulators - therapeutic use</subject><subject>Estrogen Replacement Therapy</subject><subject>Evidence-based medicine</subject><subject>Evidence-Based Medicine - methods</subject><subject>Female</subject><subject>General & internal medicine</subject><subject>Human health sciences</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Menopause</subject><subject>Médecine générale & interne</subject><subject>Organometallic Compounds - therapeutic use</subject><subject>Orthopedics</subject><subject>Osteoporosis</subject><subject>Osteoporosis, Postmenopausal - drug therapy</subject><subject>Osteoporosis. Osteomalacia. Paget disease</subject><subject>Osteoporotic Fractures - prevention & control</subject><subject>Pharmacology. Drug treatments</subject><subject>Raloxifene</subject><subject>Rheumatology</subject><subject>Sciences de la santé humaine</subject><subject>strontium</subject><subject>Teriparatide</subject><subject>Thiophenes - therapeutic use</subject><subject>Womens health</subject><issn>0937-941X</issn><issn>1433-2965</issn><issn>1433-2965</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFUsuO1DAQjBCIHQY-gAtYSIhTwHZsJ-aAxI6Wh7QSB1iJm9Vx7IxXGTtrJyPtJ_DXeB7sAAc4uVtdVd3urqJ4SvBrgnH9JmFMZFNigktCaVWye8WCsKoqqRT8frHAsqpLycj3s-JRStc4c6SsHxZnFLMGE9Ysih8XW9cZr03ZQjId6uecDs6bhGyIaFobNK4hbkCHIfROw4CmaGDaGD-hYNEY0i4OI8wp13JmwhhiSC69RYB08Mn4NCfUBT3vSe3tXvXcDL0Dj86DN2g1zO3j4oGFIZknx3dZXH24-Lb6VF5--fh59f6y1EJUU9lRyShgkFRYzRlY0UHVcGCaayw6SwgmFWa0pk1HtW2pAMkNaEu5bUxDqmXx7qA7zu3GdDrPFGFQY3QbiLcqgFN_Vrxbqz5sFZUVqQXNAvQgMDjTGxVi69SW7on7eB56BVq1RlEqGlVjQngmvTp2jeFmNmlSG5e0GQbwJsxJSc4ExUKK_yJrzvIheb7zsnjxF_I6zNHn5WUQpqSmTGYQOYB0PkqKxt79lGC1c5E6uEjhXZ5dpHbCz35f0R3jl20y4OURAClbwkbw2qUTrqKs5nV9WlXKJd-beJrwX92fH0gWgoI-ZuGrr3R3VdI0nFFS_QQI2OsY</recordid><startdate>20101001</startdate><enddate>20101001</enddate><creator>Body, J.-J</creator><creator>Bergmann, P</creator><creator>Boonen, S</creator><creator>Boutsen, Y</creator><creator>Devogelaer, J.-P</creator><creator>Goemaere, S</creator><creator>Kaufman, J.-M</creator><creator>Rozenberg, S</creator><creator>Reginster, J.-Y</creator><general>London : Springer-Verlag</general><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><general>Springer Science & Business Media B.V</general><scope>FBQ</scope><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>Q33</scope><scope>5PM</scope></search><sort><creationdate>20101001</creationdate><title>Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club</title><author>Body, J.-J ; Bergmann, P ; Boonen, S ; Boutsen, Y ; Devogelaer, J.-P ; Goemaere, S ; Kaufman, J.-M ; Rozenberg, S ; Reginster, J.-Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c663t-d2942a0a926fc54af6da385a4c5c06df11013042728d2cfb26a95eacf25f8e813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Bisphosphonate</topic><topic>Bone Density Conservation Agents - therapeutic use</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Consensus Statement</topic><topic>Diphosphonates - therapeutic use</topic><topic>Diseases of the osteoarticular system</topic><topic>Drug therapy</topic><topic>Endocrinology</topic><topic>Estrogen Receptor Modulators - therapeutic use</topic><topic>Estrogen Replacement Therapy</topic><topic>Evidence-based medicine</topic><topic>Evidence-Based Medicine - methods</topic><topic>Female</topic><topic>General & internal medicine</topic><topic>Human health sciences</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Menopause</topic><topic>Médecine générale & interne</topic><topic>Organometallic Compounds - therapeutic use</topic><topic>Orthopedics</topic><topic>Osteoporosis</topic><topic>Osteoporosis, Postmenopausal - drug therapy</topic><topic>Osteoporosis. Osteomalacia. Paget disease</topic><topic>Osteoporotic Fractures - prevention & control</topic><topic>Pharmacology. Drug treatments</topic><topic>Raloxifene</topic><topic>Rheumatology</topic><topic>Sciences de la santé humaine</topic><topic>strontium</topic><topic>Teriparatide</topic><topic>Thiophenes - therapeutic use</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Body, J.-J</creatorcontrib><creatorcontrib>Bergmann, P</creatorcontrib><creatorcontrib>Boonen, S</creatorcontrib><creatorcontrib>Boutsen, Y</creatorcontrib><creatorcontrib>Devogelaer, J.-P</creatorcontrib><creatorcontrib>Goemaere, S</creatorcontrib><creatorcontrib>Kaufman, J.-M</creatorcontrib><creatorcontrib>Rozenberg, S</creatorcontrib><creatorcontrib>Reginster, J.-Y</creatorcontrib><collection>AGRIS</collection><collection>Springer Nature OA/Free Journals</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Université de Liège - Open Repository and Bibliography (ORBI)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Osteoporosis international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Body, J.-J</au><au>Bergmann, P</au><au>Boonen, S</au><au>Boutsen, Y</au><au>Devogelaer, J.-P</au><au>Goemaere, S</au><au>Kaufman, J.-M</au><au>Rozenberg, S</au><au>Reginster, J.-Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club</atitle><jtitle>Osteoporosis international</jtitle><stitle>Osteoporos Int</stitle><addtitle>Osteoporos Int</addtitle><date>2010-10-01</date><risdate>2010</risdate><volume>21</volume><issue>10</issue><spage>1657</spage><epage>1680</epage><pages>1657-1680</pages><issn>0937-941X</issn><issn>1433-2965</issn><eissn>1433-2965</eissn><abstract>Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the specificities of each and every health care environment. The present manuscript is the result of a National Consensus, based on a systematic review and a critical appraisal of the currently available literature. It offers an evidence-based update of previous treatment guidelines, with the aim of providing clinicians with an unbiased assessment of osteoporosis treatment effect.</abstract><cop>London</cop><pub>London : Springer-Verlag</pub><pmid>20480148</pmid><doi>10.1007/s00198-010-1223-4</doi><tpages>24</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0937-941X |
| ispartof | Osteoporosis international, 2010-10, Vol.21 (10), p.1657-1680 |
| issn | 0937-941X 1433-2965 1433-2965 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2931762 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Aged Aged, 80 and over Biological and medical sciences Bisphosphonate Bone Density Conservation Agents - therapeutic use Bones, joints and connective tissue. Antiinflammatory agents Consensus Statement Diphosphonates - therapeutic use Diseases of the osteoarticular system Drug therapy Endocrinology Estrogen Receptor Modulators - therapeutic use Estrogen Replacement Therapy Evidence-based medicine Evidence-Based Medicine - methods Female General & internal medicine Human health sciences Humans Medical sciences Medicine Medicine & Public Health Menopause Médecine générale & interne Organometallic Compounds - therapeutic use Orthopedics Osteoporosis Osteoporosis, Postmenopausal - drug therapy Osteoporosis. Osteomalacia. Paget disease Osteoporotic Fractures - prevention & control Pharmacology. Drug treatments Raloxifene Rheumatology Sciences de la santé humaine strontium Teriparatide Thiophenes - therapeutic use Womens health |
| title | Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T01%3A41%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence-based%20guidelines%20for%20the%20pharmacological%20treatment%20of%20postmenopausal%20osteoporosis:%20a%20consensus%20document%20by%20the%20Belgian%20Bone%20Club&rft.jtitle=Osteoporosis%20international&rft.au=Body,%20J.-J&rft.date=2010-10-01&rft.volume=21&rft.issue=10&rft.spage=1657&rft.epage=1680&rft.pages=1657-1680&rft.issn=0937-941X&rft.eissn=1433-2965&rft_id=info:doi/10.1007/s00198-010-1223-4&rft_dat=%3Cproquest_pubme%3E2135492511%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=750217249&rft_id=info:pmid/20480148&rfr_iscdi=true |